Education
About Us
Working with TipRanks
Follow Us
Bahija Jallal Insider Profile
4 Followers
Bahija Jallal, Director at Guardant Health, holds 4.19K shares in Elevance Health (Ticker: ELV), holds 7.41K shares in Guardant Health (Ticker: GH), holds ― shares in ArriVent BioPharma, Inc. (Ticker: AVBP).
Bahija Jallal has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bahija Jallal holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Bahija Jallal
Bahija Jallal's Trading History
Guardant Health
Jun 17, 2022
Director
Uninformative Buy
69.69K
$291.28K
Elevance Health
May 17, 2024
Director
Uninformative Buy
―
$1.71M
ArriVent BioPharma, Inc.
―
Director
―
―
Immunocore Holdings
―
CEO, Director
―
―
List of latest transactions for each holding click on a transaction to see Bahija Jallal's performance on stock
You May Also Like
Bahija Jallal insider profile FAQ
What is the percentage of profitable transactions made by Bahija Jallal?
The percentage of profitable transactions made by Bahija Jallal is ―.
What is the average return per transaction made by Bahija Jallal?
The average return per transaction made by Bahija Jallal is ―.
What stocks does Bahija Jallal hold?
Bahija Jallal holds: GH, ELV, AVBP, IMCR stocks.
What was Bahija Jallal’s latest transaction?
Bahija Jallal latest transaction was an Uninformative Buy of ―.
What was Bahija Jallal's most profitable transaction?
Bahija Jallal’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Bahija Jallal's role in Guardant Health?
Bahija Jallal's role in Guardant Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.